Dr Gilles Robichaud is a Professor at the Université de Moncton and a Senior Researcher at the Atlantic Cancer Research Institute (Moncton, NB, Canada). Dr Robichaud obtained his PhD in Microbiology-Immunology (2001) and has completed his postdoctoral fellowships in cancer biology (2003) and RNA Biology (2006). Dr. Robichaud’s research program focuses on molecular and cellular mechanisms supporting biological processes and disease. Since 2006, Dr Robichaud's research projects have also enabled the supervision and graduation of over 100 students at all academic levels (BSc, MSc, PhD, and PDF). Dr Robichaud also acknowledges all financial support, which have been provided by funding programs such as: the Canadian Institutes of Health Research; the National Sciences and Engineering Research Council of Canada; the Leukemia and Lymphoma Society of Canada; the Breast Cancer Society; the Canadian Cancer Society; the Beatrice Hunter Cancer Research Institute; the NB Health Research Foundation; and the NB Innovation Foundation.
Research Keywords & Expertise
non-coding RNA
gene regulation and ex...
cancer pathogenesis
Cell signal transducti...
Fingerprints
14%
cancer pathogenesis
5%
gene regulation and expression
5%
non-coding RNA
Short Biography
Dr Gilles Robichaud is a Professor at the Université de Moncton and a Senior Researcher at the Atlantic Cancer Research Institute (Moncton, NB, Canada). Dr Robichaud obtained his PhD in Microbiology-Immunology (2001) and has completed his postdoctoral fellowships in cancer biology (2003) and RNA Biology (2006). Dr. Robichaud’s research program focuses on molecular and cellular mechanisms supporting biological processes and disease. Since 2006, Dr Robichaud's research projects have also enabled the supervision and graduation of over 100 students at all academic levels (BSc, MSc, PhD, and PDF). Dr Robichaud also acknowledges all financial support, which have been provided by funding programs such as: the Canadian Institutes of Health Research; the National Sciences and Engineering Research Council of Canada; the Leukemia and Lymphoma Society of Canada; the Breast Cancer Society; the Canadian Cancer Society; the Beatrice Hunter Cancer Research Institute; the NB Health Research Foundation; and the NB Innovation Foundation.
Well done!
